Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Fauci urges Americans to get any of the three COVID-19 vaccines available

Published 2021-02-28, 09:20 a/m
© Reuters. FILE PHOTO: Fauci addresses the daily press briefing at the White House in Washington
PFE
-
JNJ
-

By Andy Sullivan

WASHINGTON (Reuters) - Dr. Anthony Fauci, the top U.S. infectious disease official, said on Sunday he would take the newly approved Johnson & Johnson (NYSE:JNJ) COVID-19 vaccine, as he encouraged Americans to accept any of the three approved shots.

"All three of them are really quite good, and people should take the one that's most available to them. If you go to a place and you have J&J, and that's the one that's available now, I would take it," Fauci said on NBC's "Meet the Press."

The U.S. government authorized Johnson & Johnson's single-dose COVID-19 vaccine on Saturday, making it the third to be available in the country following ones from Pfizer/BioNTech and Moderna. Both of those vaccines require two doses and need to be shipped frozen. The J&J vaccine can be shipped and stored at normal refrigerator temperatures.

The J&J vaccine is expected to get final approval for widespread use on Sunday, and shipments are expected to begin Sunday or Monday.

Both the Pfizer (NYSE:PFE) and Moderna vaccines showed higher efficacy rates in trials that used two doses versus J&J's single-shot vaccine. However, Fauci and other experts say direct comparison is difficult because the trials had different goals and J&J's was conducted while more contagious new variants of the virus were circulating.

Fauci said studies are now underway to determine their effectiveness and safety for children under 18, who are less likely to get sick from the virus.

Elementary-school students could get doses toward the end of the year or the beginning of next year, while high-school students could get it in the fall, Fauci said.

The new vaccine gives the U.S. government another option as it tries to immunize as many Americans as quickly as possible. About 14% of Americans have received at least one dose so far, according to government data.

President Joe Biden has said there should be enough supply to vaccinate all Americans by the end of July.

COVID-19 has claimed more than half a million lives in the United States, and states are clamoring for more doses to stem cases, hospitalizations and deaths. (Graphic: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/)

Daily infections have declined dramatically since their January peak, and some states have begun to loosen restrictions on public gatherings. However, Fauci warned that caseloads could rise again if officials move too quickly.

© Reuters. FILE PHOTO: Fauci addresses the daily press briefing at the White House in Washington

"It's really too premature right now to be pulling back too much," he said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.